UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 151

Sortiert nach

Interaction of Cisplatin with the Human Organic Cation Transporter 2

Clinical cancer research, 2008-06, Vol.14 (12), p.3875-3880

2008

Volltextzugriff (PDF)

Drug Transporters and Imatinib Treatment: Implications for Clinical Practice

Clinical cancer research, 2011-02, Vol.17 (3), p.406-415

2011

Volltextzugriff (PDF)

A Long-term Prospective Population Pharmacokinetic Study on Imatinib Plasma Concentrations in GIST Patients

Clinical cancer research, 2012-10, Vol.18 (20), p.5780-5787

2012

Volltextzugriff (PDF)

Influence of polymorphic OATP1B-type carriers on the disposition of docetaxel

Clinical cancer research, 2012-08, Vol.18 (16), p.4433-4440

2012

Volltextzugriff (PDF)

Toward Prediction of Efficacy of Chemotherapy: A Proof of Concept Study in Lung Cancer Patients Using [11C]docetaxel and Positron Emission Tomography

Clinical cancer research, 2013-08, Vol.19 (15), p.4163-4173

2013

Volltextzugriff (PDF)

Therapeutic Drug Monitoring for the Individualization of Docetaxel Dosing: A Randomized Pharmacokinetic Study

Clinical cancer research, 2011-01, Vol.17 (2), p.353-362

2011

Volltextzugriff (PDF)

Association of CYP2C8, CYP3A4, CYP3A5, and ABCB1 Polymorphisms with the Pharmacokinetics of Paclitaxel

Clinical cancer research, 2005-11, Vol.11 (22), p.8097-8104

2005

Volltextzugriff (PDF)

Mapatumumab, a Fully Human Agonistic Monoclonal Antibody That Targets TRAIL-R1, in Combination with Gemcitabine and Cisplatin: a Phase I Study

Clinical cancer research, 2009-09, Vol.15 (17), p.5584-5590

2009

Volltextzugriff (PDF)

A CYP3A4 Phenotype–Based Dosing Algorithm for Individualized Treatment of Irinotecan

Clinical cancer research, 2010-01, Vol.16 (2), p.736-742

2010

Volltextzugriff (PDF)

Cigarette Smoking and Irinotecan Treatment: Pharmacokinetic Interaction and Effects on Neutropenia

Journal of clinical oncology, 2007-07, Vol.25 (19), p.2719-2726

2007

Volltextzugriff (PDF)

Cisplatin-Induced Downregulation of OCTN2 Affects Carnitine Wasting

Clinical cancer research, 2010-10, Vol.16 (19), p.4789-4799

2010

Volltextzugriff (PDF)

Dextromethorphan As a Phenotyping Test to Predict Endoxifen Exposure in Patients on Tamoxifen Treatment

Journal of clinical oncology, 2011-08, Vol.29 (24), p.3240-3246

2011

Volltextzugriff (PDF)

Influence of Smoking on the Pharmacokinetics and Toxicity Profiles of Taxane Therapy

Clinical cancer research, 2012-08, Vol.18 (16), p.4425-4432

2012

Volltextzugriff (PDF)

Quantification of tamoxifen and three of its phase-I metabolites in human plasma by liquid chromatography/triple-quadrupole mass spectrometry

Journal of pharmaceutical and biomedical analysis, 2011-12, Vol.56 (5), p.1016-1023

2011

Volltextzugriff (PDF)

Drug transporters of platinum-based anticancer agents and their clinical significance

Drug resistance updates, 2011-02, Vol.14 (1), p.22-34

2011

Volltextzugriff (PDF)

Effect of omeprazole on the pharmacokinetics and toxicities of irinotecan in cancer patients: A prospective cross-over drug–drug interaction study

European journal of cancer (1990), 2011-04, Vol.47 (6), p.831-838

2011

Volltextzugriff (PDF)

Body-Surface Area–Based Dosing Does Not Increase Accuracy of Predicting Cisplatin Exposure

Journal of clinical oncology, 2001-09, Vol.19 (17), p.3733-3739

2001

Volltextzugriff (PDF)

Pharmacological effects of formulation vehicles: Implications for cancer chemotherapy

Clinical pharmacokinetics, 2003-01, Vol.42 (7), p.665-685

2003

Volltextzugriff (PDF)

Increasing tumoral 5-fluorouracil concentrations during a 5-day continuous infusion: a microdialysis study

Cancer chemotherapy and pharmacology, 2011-05, Vol.67 (5), p.1055-1062

2011

Volltextzugriff (PDF)

Clinical Pharmacokinetics and Metabolism of Irinotecan (CPT-11)

Clinical cancer research, 2001-08, Vol.7 (8), p.2182-2194

2001

Volltextzugriff (PDF)

Measurement of fraction unbound paclitaxel in human plasma

Drug metabolism and disposition, 2000-10, Vol.28 (10), p.1141

2000

Volltextzugriff (PDF)

Effects of St. John's Wort on Irinotecan Metabolism

JNCI : Journal of the National Cancer Institute, 2002-08, Vol.94 (16), p.1247-1249

2002

Volltextzugriff (PDF)

Evaluation of an Alternate Dosing Strategy for Cisplatin in Patients With Extreme Body Surface Area Values

Journal of clinical oncology, 2006-04, Vol.24 (10), p.1499-1506

2006

Volltextzugriff (PDF)

Influence of high-dose ketoconazole on the pharmacokinetics of docetaxel

Cancer biology & therapy, 2006-07, Vol.5 (7), p.833-839

2006

Volltextzugriff (PDF)

The Pharmacologic Basis of Ifosfamide Use in Adult Patients with Advanced Soft Tissue Sarcomas

The oncologist (Dayton, Ohio), 2007-11, Vol.12 (11), p.1351-1360

2007

Volltextzugriff (PDF)

1 – 25 von 151

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(140)
Mit Volltextzugriff
(139)

Publikationsform

Sprache

Englisch
(150)
Japanisch
(34)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(126)
Humans
(118)
Life Sciences & Biomedicine
(114)
Biological And Medical Sciences
(68)
Medical Sciences
(64)
Female
(63)
Oncology
(62)
Male
(60)
Middle Aged
(57)
Pharmacology. Drug Treatments
(57)
Adult
(52)
Aged
(48)
Antineoplastic Agents
(45)
Antineoplastic Agents - Pharmacokinetics
(39)
Pharmacology & Pharmacy
(35)
Neoplasms - Drug Therapy
(31)
Camptothecin - Analogs & Derivatives
(28)
Chemotherapy
(27)
Antineoplastic Agents - Administration & Dosage
(25)
Antineoplastic Agents, Phytogenic - Pharmacokinetics
(24)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Interaction of Cisplatin with the Human Organic Cation Transporter 2

Drug Transporters and Imatinib Treatment: Implications for Clinical Practice

A Long-term Prospective Population Pharmacokinetic Study on Imatinib Plasma Concentrations in GIST Patients

Influence of polymorphic OATP1B-type carriers on the disposition of docetaxel

Toward Prediction of Efficacy of Chemotherapy: A Proof of Concept Study in Lung Cancer Patients Using [11C]docetaxel and Positron Emission Tomography

Therapeutic Drug Monitoring for the Individualization of Docetaxel Dosing: A Randomized Pharmacokinetic Study

Association of CYP2C8, CYP3A4, CYP3A5, and ABCB1 Polymorphisms with the Pharmacokinetics of Paclitaxel

Mapatumumab, a Fully Human Agonistic Monoclonal Antibody That Targets TRAIL-R1, in Combination with Gemcitabine and Cisplatin: a Phase I Study

A CYP3A4 Phenotype–Based Dosing Algorithm for Individualized Treatment of Irinotecan

Cigarette Smoking and Irinotecan Treatment: Pharmacokinetic Interaction and Effects on Neutropenia

Cisplatin-Induced Downregulation of OCTN2 Affects Carnitine Wasting

Dextromethorphan As a Phenotyping Test to Predict Endoxifen Exposure in Patients on Tamoxifen Treatment

Influence of Smoking on the Pharmacokinetics and Toxicity Profiles of Taxane Therapy

Quantification of tamoxifen and three of its phase-I metabolites in human plasma by liquid chromatography/triple-quadrupole mass spectrometry

Drug transporters of platinum-based anticancer agents and their clinical significance

Effect of omeprazole on the pharmacokinetics and toxicities of irinotecan in cancer patients: A prospective cross-over drug–drug interaction study

Body-Surface Area–Based Dosing Does Not Increase Accuracy of Predicting Cisplatin Exposure

Pharmacological effects of formulation vehicles: Implications for cancer chemotherapy

Increasing tumoral 5-fluorouracil concentrations during a 5-day continuous infusion: a microdialysis study

Clinical Pharmacokinetics and Metabolism of Irinotecan (CPT-11)

Measurement of fraction unbound paclitaxel in human plasma

Effects of St. John's Wort on Irinotecan Metabolism

Evaluation of an Alternate Dosing Strategy for Cisplatin in Patients With Extreme Body Surface Area Values

Influence of high-dose ketoconazole on the pharmacokinetics of docetaxel

The Pharmacologic Basis of Ifosfamide Use in Adult Patients with Advanced Soft Tissue Sarcomas

Suchergebnisse filtern